Search

Your search keyword '"Loken, Michael R."' showing total 28 results
Start Over Author "Loken, Michael R." Publisher american association for cancer research (aacr)
28 results on '"Loken, Michael R."'

1. Supplementary Figures from Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Author

Smith, Jenny L., primary, Ries, Rhonda E., primary, Hylkema, Tiffany, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Santaguida, Marianne T., primary, Eidenschink Brodersen, Lisa, primary, Pardo, Laura, primary, Cummings, Carrie L., primary, Loeb, Keith R., primary, Le, Quy, primary, Imren, Suzan, primary, Leonti, Amanda R., primary, Gamis, Alan S., primary, Aplenc, Richard, primary, Kolb, E. Anders, primary, Farrar, Jason E., primary, Triche, Timothy J., primary, Nguyen, Cu, primary, Meerzaman, Daoud, primary, Loken, Michael R., primary, Oehler, Vivian G., primary, Bolouri, Hamid, primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Table 2 from Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy

Author

Mortland, Leslie, primary, Alonzo, Todd A., primary, Walter, Roland B., primary, Gerbing, Robert B., primary, Mitra, Amit K., primary, Pollard, Jessica A., primary, Loken, Michael R., primary, Hirsch, Betsy, primary, Raimondi, Susana, primary, Franklin, Janet, primary, Pounds, Stanley, primary, Cao, Xueyuan, primary, Rubnitz, Jeffrey E., primary, Ribeiro, Raul C., primary, Gamis, Alan, primary, Meshinchi, Soheil, primary, and Lamba, Jatinder K., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table 1 from Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Raimondi, Susana C., primary, Hirsch, Betsy A., primary, Sung, Lillian, primary, Pollard, Jessica A., primary, Aplenc, Richard, primary, Loken, Michael R., primary, Gamis, Alan S., primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

4. Table S1 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Wang, Yi-Cheng, primary, Gerbing, Robert B., primary, Ries, Rhonda, primary, Loken, Michael R., primary, Pardo, Laura, primary, Hylkema, Tiffany, primary, Joaquin, Jason, primary, Sarukkai, Leela, primary, Raimondi, Susana C., primary, Hirsch, Betsy, primary, Sung, Lillian, primary, Aplenc, Richard, primary, Bernstein, Irwin, primary, Gamis, Alan S., primary, Meshinchi, Soheil, primary, and Pollard, Jessica A., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table 2 from Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy

Author

Mortland, Leslie, primary, Alonzo, Todd A., primary, Walter, Roland B., primary, Gerbing, Robert B., primary, Mitra, Amit K., primary, Pollard, Jessica A., primary, Loken, Michael R., primary, Hirsch, Betsy, primary, Raimondi, Susana, primary, Franklin, Janet, primary, Pounds, Stanley, primary, Cao, Xueyuan, primary, Rubnitz, Jeffrey E., primary, Ribeiro, Raul C., primary, Gamis, Alan, primary, Meshinchi, Soheil, primary, and Lamba, Jatinder K., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Methods from Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Author

Smith, Jenny L., primary, Ries, Rhonda E., primary, Hylkema, Tiffany, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Santaguida, Marianne T., primary, Eidenschink Brodersen, Lisa, primary, Pardo, Laura, primary, Cummings, Carrie L., primary, Loeb, Keith R., primary, Le, Quy, primary, Imren, Suzan, primary, Leonti, Amanda R., primary, Gamis, Alan S., primary, Aplenc, Richard, primary, Kolb, E. Anders, primary, Farrar, Jason E., primary, Triche, Timothy J., primary, Nguyen, Cu, primary, Meerzaman, Daoud, primary, Loken, Michael R., primary, Oehler, Vivian G., primary, Bolouri, Hamid, primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table 2 from Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Loken, Michael R., primary, Gerbing, Robert B., primary, Ries, Rhonda E., primary, Aplenc, Richard, primary, Sung, Lillian, primary, Raimondi, Susana C., primary, Hirsch, Betsy A., primary, Kahwash, Samir B., primary, McKenney, Amy, primary, Kolb, E. Anders, primary, Gamis, Alan S., primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Methods from Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Author

Smith, Jenny L., primary, Ries, Rhonda E., primary, Hylkema, Tiffany, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Santaguida, Marianne T., primary, Eidenschink Brodersen, Lisa, primary, Pardo, Laura, primary, Cummings, Carrie L., primary, Loeb, Keith R., primary, Le, Quy, primary, Imren, Suzan, primary, Leonti, Amanda R., primary, Gamis, Alan S., primary, Aplenc, Richard, primary, Kolb, E. Anders, primary, Farrar, Jason E., primary, Triche, Timothy J., primary, Nguyen, Cu, primary, Meerzaman, Daoud, primary, Loken, Michael R., primary, Oehler, Vivian G., primary, Bolouri, Hamid, primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 2 from Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Raimondi, Susana C., primary, Hirsch, Betsy A., primary, Sung, Lillian, primary, Pollard, Jessica A., primary, Aplenc, Richard, primary, Loken, Michael R., primary, Gamis, Alan S., primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figures from Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Author

Smith, Jenny L., primary, Ries, Rhonda E., primary, Hylkema, Tiffany, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Santaguida, Marianne T., primary, Eidenschink Brodersen, Lisa, primary, Pardo, Laura, primary, Cummings, Carrie L., primary, Loeb, Keith R., primary, Le, Quy, primary, Imren, Suzan, primary, Leonti, Amanda R., primary, Gamis, Alan S., primary, Aplenc, Richard, primary, Kolb, E. Anders, primary, Farrar, Jason E., primary, Triche, Timothy J., primary, Nguyen, Cu, primary, Meerzaman, Daoud, primary, Loken, Michael R., primary, Oehler, Vivian G., primary, Bolouri, Hamid, primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

12. Table S4 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Wang, Yi-Cheng, primary, Gerbing, Robert B., primary, Ries, Rhonda, primary, Loken, Michael R., primary, Pardo, Laura, primary, Hylkema, Tiffany, primary, Joaquin, Jason, primary, Sarukkai, Leela, primary, Raimondi, Susana C., primary, Hirsch, Betsy, primary, Sung, Lillian, primary, Aplenc, Richard, primary, Bernstein, Irwin, primary, Gamis, Alan S., primary, Meshinchi, Soheil, primary, and Pollard, Jessica A., primary

Published
2023
Full Text
View/download PDF

13. Figure S1 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Wang, Yi-Cheng, primary, Gerbing, Robert B., primary, Ries, Rhonda, primary, Loken, Michael R., primary, Pardo, Laura, primary, Hylkema, Tiffany, primary, Joaquin, Jason, primary, Sarukkai, Leela, primary, Raimondi, Susana C., primary, Hirsch, Betsy, primary, Sung, Lillian, primary, Aplenc, Richard, primary, Bernstein, Irwin, primary, Gamis, Alan S., primary, Meshinchi, Soheil, primary, and Pollard, Jessica A., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table 1 from Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Loken, Michael R., primary, Gerbing, Robert B., primary, Ries, Rhonda E., primary, Aplenc, Richard, primary, Sung, Lillian, primary, Raimondi, Susana C., primary, Hirsch, Betsy A., primary, Kahwash, Samir B., primary, McKenney, Amy, primary, Kolb, E. Anders, primary, Gamis, Alan S., primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 4 from Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Raimondi, Susana C., primary, Hirsch, Betsy A., primary, Sung, Lillian, primary, Pollard, Jessica A., primary, Aplenc, Richard, primary, Loken, Michael R., primary, Gamis, Alan S., primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

16. Table S5 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Wang, Yi-Cheng, primary, Gerbing, Robert B., primary, Ries, Rhonda, primary, Loken, Michael R., primary, Pardo, Laura, primary, Hylkema, Tiffany, primary, Joaquin, Jason, primary, Sarukkai, Leela, primary, Raimondi, Susana C., primary, Hirsch, Betsy, primary, Sung, Lillian, primary, Aplenc, Richard, primary, Bernstein, Irwin, primary, Gamis, Alan S., primary, Meshinchi, Soheil, primary, and Pollard, Jessica A., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 3 from Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Raimondi, Susana C., primary, Hirsch, Betsy A., primary, Sung, Lillian, primary, Pollard, Jessica A., primary, Aplenc, Richard, primary, Loken, Michael R., primary, Gamis, Alan S., primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Tables from Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Author

Smith, Jenny L., primary, Ries, Rhonda E., primary, Hylkema, Tiffany, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Santaguida, Marianne T., primary, Eidenschink Brodersen, Lisa, primary, Pardo, Laura, primary, Cummings, Carrie L., primary, Loeb, Keith R., primary, Le, Quy, primary, Imren, Suzan, primary, Leonti, Amanda R., primary, Gamis, Alan S., primary, Aplenc, Richard, primary, Kolb, E. Anders, primary, Farrar, Jason E., primary, Triche, Timothy J., primary, Nguyen, Cu, primary, Meerzaman, Daoud, primary, Loken, Michael R., primary, Oehler, Vivian G., primary, Bolouri, Hamid, primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table 1 from Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy

Author

Mortland, Leslie, primary, Alonzo, Todd A., primary, Walter, Roland B., primary, Gerbing, Robert B., primary, Mitra, Amit K., primary, Pollard, Jessica A., primary, Loken, Michael R., primary, Hirsch, Betsy, primary, Raimondi, Susana, primary, Franklin, Janet, primary, Pounds, Stanley, primary, Cao, Xueyuan, primary, Rubnitz, Jeffrey E., primary, Ribeiro, Raul C., primary, Gamis, Alan, primary, Meshinchi, Soheil, primary, and Lamba, Jatinder K., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure 1 from Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Gerbing, Robert B., primary, Raimondi, Susana C., primary, Hirsch, Betsy A., primary, Sung, Lillian, primary, Pollard, Jessica A., primary, Aplenc, Richard, primary, Loken, Michael R., primary, Gamis, Alan S., primary, and Meshinchi, Soheil, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Table 1 from Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy

Author

Mortland, Leslie, primary, Alonzo, Todd A., primary, Walter, Roland B., primary, Gerbing, Robert B., primary, Mitra, Amit K., primary, Pollard, Jessica A., primary, Loken, Michael R., primary, Hirsch, Betsy, primary, Raimondi, Susana, primary, Franklin, Janet, primary, Pounds, Stanley, primary, Cao, Xueyuan, primary, Rubnitz, Jeffrey E., primary, Ribeiro, Raul C., primary, Gamis, Alan, primary, Meshinchi, Soheil, primary, and Lamba, Jatinder K., primary

Published
2023
Full Text
View/download PDF

22. Figure S2 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Author

Tarlock, Katherine, primary, Alonzo, Todd A., primary, Wang, Yi-Cheng, primary, Gerbing, Robert B., primary, Ries, Rhonda, primary, Loken, Michael R., primary, Pardo, Laura, primary, Hylkema, Tiffany, primary, Joaquin, Jason, primary, Sarukkai, Leela, primary, Raimondi, Susana C., primary, Hirsch, Betsy, primary, Sung, Lillian, primary, Aplenc, Richard, primary, Bernstein, Irwin, primary, Gamis, Alan S., primary, Meshinchi, Soheil, primary, and Pollard, Jessica A., primary

Published
2023
Full Text
View/download PDF

23. Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia

Author

Le, Quy, primary, Castro, Sommer, additional, Tang, Thao, additional, Loeb, Anisha M., additional, Hylkema, Tiffany, additional, McKay, Cyd Nourigat, additional, Perkins, LaKeisha, additional, Srivastava, Shivani, additional, Call, Lindsey, additional, Smith, Jenny, additional, Leonti, Amanda, additional, Ries, Rhonda, additional, Pardo, Laura, additional, Loken, Michael R., additional, Correnti, Colin, additional, Fiorenza, Salvatore, additional, Turtle, Cameron J., additional, Riddell, Stanley, additional, Tarlock, Katherine, additional, and Meshinchi, Soheil, additional

Published
2021
Full Text
View/download PDF

24. Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Author

Smith, Jenny L., primary, Ries, Rhonda E., additional, Hylkema, Tiffany, additional, Alonzo, Todd A., additional, Gerbing, Robert B., additional, Santaguida, Marianne T., additional, Eidenschink Brodersen, Lisa, additional, Pardo, Laura, additional, Cummings, Carrie L., additional, Loeb, Keith R., additional, Le, Quy, additional, Imren, Suzan, additional, Leonti, Amanda R., additional, Gamis, Alan S., additional, Aplenc, Richard, additional, Kolb, E. Anders, additional, Farrar, Jason E., additional, Triche, Timothy J., additional, Nguyen, Cu, additional, Meerzaman, Daoud, additional, Loken, Michael R., additional, Oehler, Vivian G., additional, Bolouri, Hamid, additional, and Meshinchi, Soheil, additional

Published
2020
Full Text
View/download PDF

25. Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Author

Tarlock, Katherine, primary, Alonzo, Todd A., additional, Wang, Yi-Cheng, additional, Gerbing, Robert B., additional, Ries, Rhonda, additional, Loken, Michael R., additional, Pardo, Laura, additional, Hylkema, Tiffany, additional, Joaquin, Jason, additional, Sarukkai, Leela, additional, Raimondi, Susana C., additional, Hirsch, Betsy, additional, Sung, Lillian, additional, Aplenc, Richard, additional, Bernstein, Irwin, additional, Gamis, Alan S., additional, Meshinchi, Soheil, additional, and Pollard, Jessica A., additional

Published
2019
Full Text
View/download PDF

26. Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., additional, Loken, Michael R., additional, Gerbing, Robert B., additional, Ries, Rhonda E., additional, Aplenc, Richard, additional, Sung, Lillian, additional, Raimondi, Susana C., additional, Hirsch, Betsy A., additional, Kahwash, Samir B., additional, McKenney, Amy, additional, Kolb, E. Anders, additional, Gamis, Alan S., additional, and Meshinchi, Soheil, additional

Published
2017
Full Text
View/download PDF

27. Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Author

Tarlock, Katherine, primary, Alonzo, Todd A., additional, Gerbing, Robert B., additional, Raimondi, Susana C., additional, Hirsch, Betsy A., additional, Sung, Lillian, additional, Pollard, Jessica A., additional, Aplenc, Richard, additional, Loken, Michael R., additional, Gamis, Alan S., additional, and Meshinchi, Soheil, additional

Published
2016
Full Text
View/download PDF

28. Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy

Author

Mortland, Leslie, primary, Alonzo, Todd A., additional, Walter, Roland B., additional, Gerbing, Robert B., additional, Mitra, Amit K., additional, Pollard, Jessica A., additional, Loken, Michael R., additional, Hirsch, Betsy, additional, Raimondi, Susana, additional, Franklin, Janet, additional, Pounds, Stanley, additional, Cao, Xueyuan, additional, Rubnitz, Jeffrey E., additional, Ribeiro, Raul C., additional, Gamis, Alan, additional, Meshinchi, Soheil, additional, and Lamba, Jatinder K., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results